Donatella Tondi

Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture

Stefania Ferrari, Maria Paola Costi, Glauco Ponterini, 2012 .

A multidisciplinary approach to the design of novel inhibitors for KPC-2

Donatella Tondi, Giuseppe Celenza, Pierangelo Bellio, 2017 .

First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase

Donatella Tondi, Paolo Benedetti, Massimo Baroni, 2019, Journal of Computer-Aided Molecular Design.

Finanziamento regionale Spinner per progetti di impresa.

Maria Paola Costi, Donatella Tondi, Alberto Venturelli, 2005 .

Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase

Maria Paola Costi, Daniela Cardinale, Giambattista Guaitoli, 2011, Proceedings of the National Academy of Sciences.

Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy.

Giuseppe Cannazza, Maria Paola Costi, Donatella Tondi, 2007, Journal of medicinal chemistry.

Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell culture.

Maria Paola Costi, Donatella Tondi, Richard Bonnet, 2005, Journal of the American Chemical Society.

Structure-Based Optimization of a Non-β-lactam Lead Results in Inhibitors That Do Not Up-Regulate β-Lactamase Expression in Cell Culture

Maria Paola Costi, Donatella Tondi, Richard Bonnet, 2005 .

Structural study of phenyl boronic acid derivatives as AmpC beta-lactamase inhibitors.

Brian K. Shoichet, Maria Paola Costi, Donatella Tondi, 2010, Bioorganic & medicinal chemistry letters.